Who owns CNTX?
Institutional ownership of Context Therapeutics Inc. from Form 13F, Q2 2026
79 institutional managers reported holding Context Therapeutics Inc. (CNTX) in Form 13F filings for Q2 2026, with 62,808,595 shares worth $34.8M. The largest reported holder was Nextech Invest Ltd. Managers that filed both quarters cut a net 16,458,861 shares (-20.8%). 35 opened new positions and 15 sold out.
- Funds holding
- 79
- Value held
- $34.8M
- New / sold out
- 35 / 15
- Net shares, same filers
- -20.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CNTX
Share of 13F holdings is each fund's shares as a share of the 62,808,595 CNTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$2.9M
- Geode Capital Management, LLC Added+$680K
- State Street Corp Added+$654K
- Acadian Asset Management LLC New+$559K
- Renaissance Technologies LLC Added+$475K
- Vanguard Portfolio Management LLC New+$354K
- Northern Trust Corp Added+$284K
- ADAR1 Capital Management, LLC Added+$221K
- XTX Topco Ltd New+$163K
- Qube Research & Technologies Ltd Added+$136K
Biggest sellers in Q2 2026
- Great Point Partners LLC Sold out-$5.9M
- MPM Bioimpact LLC Trimmed-$5.2M
- Squadron Capital Management LLC Sold out-$2.9M
- Avidity Partners Management LP Trimmed-$2.8M
- Adage Capital Partners GP, L.l.c. Sold out-$2.6M
- Sio Capital Management, LLC Sold out-$2.4M
- Marshall Wace, LLP Trimmed-$1.4M
- Cormorant Asset Management, LP Sold out-$1.4M
- Octagon Capital Advisors LP Trimmed-$1.2M
- Blue Owl Capital Holdings LP Trimmed-$1.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $7.9M and sold $30.3M; 18 added and 13 trimmed.
Schedule 13D and 13G filings on CNTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-05-14Octagon Capital Advisors LP SCHEDULE 13G filed by Context Therapeutics Inc.Schedule 13G
- 2026-02-03Soleus Capital Master Fund, L.P. SCHEDULE 13G filed by Context Therapeutics Inc.Schedule 13G
- 2025-01-27FRANKLIN RESOURCES INC SCHEDULE 13G filed by Context Therapeutics Inc.Schedule 13G
- 2025-01-08MPM BioImpact LLC SCHEDULE 13G filed by Context Therapeutics Inc.Schedule 13G
Questions about CNTX ownership
- Who owns CNTX stock?
- 79 institutional investment managers reported CNTX positions in their Form 13F filings for Q2 2026, holding 62,808,595 shares worth $34.8M in total. Nextech Invest Ltd. reported the largest position.
- Are funds buying or selling CNTX?
- In Q2 2026, 35 managers opened new CNTX positions, 18 added, 13 trimmed and 15 sold out. Managers that filed in both quarters sold a net 16,458,861 shares.
- How current is this CNTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CNTX by CUSIP. Options are left out. CNTX news and filings · CNTX insider trades · Top funds